Zaleplon USP Related Compound BN-(3-(3-Cyanopyrazolo[1,5-α]pyrimidin-5-yl)phenyl)-N-ethylacetamideN-(3-(3-Cyanopyrazolo[1,5-±]pyrimidin-5-yl)phenyl)-N-ethylacetamideAcetamide, N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethyl-
RefChem:150170DTXCID60119788N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethyl-acetamide7-(N-Ethylacetamidophenyl)-5-(N-ethylacetamidophenyl) ZaleplonAcetamide, N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethyl-; N-[3-(3-Cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide; Zaleplon RC B CIV (USP); Zaleplon Related Compound BZaleplon Impurity 17SCHEMBL3162849ZMUMYMWAIXXLIY-UHFFFAOYSA-N
Database identifiers
CAS
478081-98-0
PubChem CID
9879548
DTXSID
DTXSID50197297
UNII
YP251266R0
Nikkaji
J2.815.515H
Properties
Computed structural properties
XLogP
1
Topological polar surface area
74.3 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
4
Rotatable bonds
3
Heavy atoms
23
Formal charge
0
Complexity
487
Physicochemical properties
Melting point
203 · 203-205 °C
Density
1.25 · 1.25±0.1 g/cm3(Predicted)
pka
-1.4 · -1.40±0.50(Predicted)
FDA UNII
251266 R0 · YP251266R0
HS Code
9999999999 · 9999999999
Safety & regulation
Safety data
hs_code
9999999999
Chemistry & industry
Applications · 1 item
Uses(N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamide) is used in the synthesis of Zaleplon (Z145000), which is a selective non-benzodiazepine GABAA receptor agonist, and a sedative-hypnotic, almost entirely used for the management/treatment of insomnia.